Daily FNArena News - Australia

While short and medium-term concerns prevail, should investors be focusing on policy, profits and positioning?

Orora has strengthened its packaging business in North America in the first quarter, with earnings growth that surprised to the upside, while Australasia remains flat.

A softer performance is likely over the December quarter for BHP Group but brokers remain confident the company can meet FY21 guidance, underpinned by key commodities.

Implant volumes in Cochlear’s major markets appear to be on the mend, which is supportive of revenue, but concerns are emerging regarding another bout of elective surgery restrictions.

South32 has reinstated its buyback program, having built up cash reserves after a solid performance in the September quarter, while kicking off 2021 unencumbered by South Africa Energy Coal is considered critical to the outlook.

Delays stemming from the pandemic amid ebbing demand conditions confront Rio Tinto, while there is also work to do to improve perceptions about its cultural sensitivity.

As investors increasingly focus on technology companies, it is timely to review the investment thesis for Audinate

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Investor focus is firmly on life sciences companies in 2020. FNArena highlights six ASX-listed entities that have been viewed positively by analysts recently

Everything needs to fall into place for Bank of Queensland to achieve an acceleration in credit growth in FY21, despite a strong balance sheet.